MARK MAGULAC: Open Payments
NPI 1427085661 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 4 payments from 3 companies in 2025. Trend: 2023 $379 · 2024 $465 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $137 |
| Vanda Pharmaceuticals Inc. | 1 | $123 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: FANAPT, LYBALVI, ARISTADA, Qelbree.
Industry payments across CA — which companies pay providers there.
